http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 13 May 2026 09:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html <p>CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.</p> <p>A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=P3zSJKwTo11UGIzhkx-EwodF6U9ehiv1rsxcWTUaRM1dwW2d18W2kJdVtRiNe-u5Lf45ml-ZjL-mn0OUH1mv4z0VpIFQaeQp_jUQymFsaofBdy6tDrMjueb3QAaHGQAyAwf1YPU3Epr7b6B5jrw5xT-WvPVo_TM8q9eaQJcmbH0=" rel="nofollow" target="_blank"><strong>https://investors.theoncologyinstitute.com/</strong></a>.</p> <p>____________________________</p> http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html Wed, 13 May 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html <p>CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.</p> <p>A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=P3zSJKwTo11UGIzhkx-EwodF6U9ehiv1rsxcWTUaRM1dwW2d18W2kJdVtRiNe-u5Lf45ml-ZjL-mn0OUH1mv4z0VpIFQaeQp_jUQymFsaofBdy6tDrMjueb3QAaHGQAyAwf1YPU3Epr7b6B5jrw5xT-WvPVo_TM8q9eaQJcmbH0=" rel="nofollow" target="_blank"><strong>https://investors.theoncologyinstitute.com/</strong></a>.</p> <p>____________________________</p> http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html Wed, 13 May 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html <p>CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.</p> <p>A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=P3zSJKwTo11UGIzhkx-EwodF6U9ehiv1rsxcWTUaRM1dwW2d18W2kJdVtRiNe-u5Lf45ml-ZjL-mn0OUH1mv4z0VpIFQaeQp_jUQymFsaofBdy6tDrMjueb3QAaHGQAyAwf1YPU3Epr7b6B5jrw5xT-WvPVo_TM8q9eaQJcmbH0=" rel="nofollow" target="_blank"><strong>https://investors.theoncologyinstitute.com/</strong></a>.</p> <p>____________________________</p> http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html Wed, 13 May 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html <p>CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.</p> <p>A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=P3zSJKwTo11UGIzhkx-EwodF6U9ehiv1rsxcWTUaRM1dwW2d18W2kJdVtRiNe-u5Lf45ml-ZjL-mn0OUH1mv4z0VpIFQaeQp_jUQymFsaofBdy6tDrMjueb3QAaHGQAyAwf1YPU3Epr7b6B5jrw5xT-WvPVo_TM8q9eaQJcmbH0=" rel="nofollow" target="_blank"><strong>https://investors.theoncologyinstitute.com/</strong></a>.</p> <p>____________________________</p> http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html Wed, 13 May 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html <p>CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.</p> <p>A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=P3zSJKwTo11UGIzhkx-EwodF6U9ehiv1rsxcWTUaRM1dwW2d18W2kJdVtRiNe-u5Lf45ml-ZjL-mn0OUH1mv4z0VpIFQaeQp_jUQymFsaofBdy6tDrMjueb3QAaHGQAyAwf1YPU3Epr7b6B5jrw5xT-WvPVo_TM8q9eaQJcmbH0=" rel="nofollow" target="_blank"><strong>https://investors.theoncologyinstitute.com/</strong></a>.</p> <p>____________________________</p> http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html Wed, 13 May 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html <p>CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.</p> <p>A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=P3zSJKwTo11UGIzhkx-EwodF6U9ehiv1rsxcWTUaRM1dwW2d18W2kJdVtRiNe-u5Lf45ml-ZjL-mn0OUH1mv4z0VpIFQaeQp_jUQymFsaofBdy6tDrMjueb3QAaHGQAyAwf1YPU3Epr7b6B5jrw5xT-WvPVo_TM8q9eaQJcmbH0=" rel="nofollow" target="_blank"><strong>https://investors.theoncologyinstitute.com/</strong></a>.</p> <p>____________________________</p> http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+to+Participate+in+B.+Riley+Securities+Institutional+Investor+Conference/26482733.html Wed, 13 May 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html <p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).</p> <p>The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html Mon, 27 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html <p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).</p> <p>The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html Mon, 27 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html <p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).</p> <p>The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html Mon, 27 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html <p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).</p> <p>The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html Mon, 27 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html <p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).</p> <p>The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html Mon, 27 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html <p>CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).</p> <p>The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Announces+First+Quarter+2026+Earnings+Release+Date+and+Conference+Call/26370693.html Mon, 27 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Corporate+News/Oncology+Institute+generates+%241.8+million+in+Medicare+savings/26303796.html <p>The Oncology Institute of Hope and Innovation (NASDAQ: TOI) achieved $1.8 million in Medicare savings during Performance Period 3 of the Centers for Medicare & Medicaid Services' Enhancing Oncology Model through its California professional corporation, according to a company statement.</p><p>The savings equated to more than $6,400 per patient episode, representing an increase from Performance Period 2, when the company generated $1.1 million in savings, or more than $3,500 per episode.</p><p>For the second consecutive performance period, TOI earned the maximum score on avoidable emergency department visits and hospital admissions. The company attributed results to its High-Value Cancer Care program, which includes http://www.streetinsider.com/Corporate+News/Oncology+Institute+generates+%241.8+million+in+Medicare+savings/26303796.html Mon, 13 Apr 2026 09:02:10 -0400 TOI TOIIW http://www.streetinsider.com/Corporate+News/Oncology+Institute+generates+%241.8+million+in+Medicare+savings/26303796.html <p>The Oncology Institute of Hope and Innovation (NASDAQ: TOI) achieved $1.8 million in Medicare savings during Performance Period 3 of the Centers for Medicare & Medicaid Services' Enhancing Oncology Model through its California professional corporation, according to a company statement.</p><p>The savings equated to more than $6,400 per patient episode, representing an increase from Performance Period 2, when the company generated $1.1 million in savings, or more than $3,500 per episode.</p><p>For the second consecutive performance period, TOI earned the maximum score on avoidable emergency department visits and hospital admissions. The company attributed results to its High-Value Cancer Care program, which includes http://www.streetinsider.com/Corporate+News/Oncology+Institute+generates+%241.8+million+in+Medicare+savings/26303796.html Mon, 13 Apr 2026 09:02:10 -0400 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Achieves+%241.8+Million+in+Medicare+Savings+in+CMS+Enhancing+Oncology+Model+Performance+Period+3%2C+Marking+Significant+Period-Over-Period+Improvement/26303732.html <p>CERRITOS, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, achieved $1.8 million in Medicare savings during Performance Period 3 of the Centers for Medicare &amp; Medicaid Services’ Enhancing Oncology Model (EOM) through its California professional corporation, with savings equating to more than $6,400 per patient episode. This represents a significant increase from Performance Period 2, when TOI generated $1.1 million in savings, or more than $3,500 per episode.</p> <p>For the second consecutive performance period, TOI earned the maximum score on avoidable emergency department visits http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Achieves+%241.8+Million+in+Medicare+Savings+in+CMS+Enhancing+Oncology+Model+Performance+Period+3%2C+Marking+Significant+Period-Over-Period+Improvement/26303732.html Mon, 13 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Achieves+%241.8+Million+in+Medicare+Savings+in+CMS+Enhancing+Oncology+Model+Performance+Period+3%2C+Marking+Significant+Period-Over-Period+Improvement/26303732.html <p>CERRITOS, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, achieved $1.8 million in Medicare savings during Performance Period 3 of the Centers for Medicare &amp; Medicaid Services’ Enhancing Oncology Model (EOM) through its California professional corporation, with savings equating to more than $6,400 per patient episode. This represents a significant increase from Performance Period 2, when TOI generated $1.1 million in savings, or more than $3,500 per episode.</p> <p>For the second consecutive performance period, TOI earned the maximum score on avoidable emergency department visits http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Achieves+%241.8+Million+in+Medicare+Savings+in+CMS+Enhancing+Oncology+Model+Performance+Period+3%2C+Marking+Significant+Period-Over-Period+Improvement/26303732.html Mon, 13 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Achieves+%241.8+Million+in+Medicare+Savings+in+CMS+Enhancing+Oncology+Model+Performance+Period+3%2C+Marking+Significant+Period-Over-Period+Improvement/26303732.html <p>CERRITOS, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, achieved $1.8 million in Medicare savings during Performance Period 3 of the Centers for Medicare &amp; Medicaid Services’ Enhancing Oncology Model (EOM) through its California professional corporation, with savings equating to more than $6,400 per patient episode. This represents a significant increase from Performance Period 2, when TOI generated $1.1 million in savings, or more than $3,500 per episode.</p> <p>For the second consecutive performance period, TOI earned the maximum score on avoidable emergency department visits http://www.streetinsider.com/Press+Releases/The+Oncology+Institute+Achieves+%241.8+Million+in+Medicare+Savings+in+CMS+Enhancing+Oncology+Model+Performance+Period+3%2C+Marking+Significant+Period-Over-Period+Improvement/26303732.html Mon, 13 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Achieves+%241.8+Million+in+Medicare+Savings+in+CMS+Enhancing+Oncology+Model+Performance+Period+3%2C+Marking+Significant+Period-Over-Period+Improvement/26303732.html <p>CERRITOS, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, achieved $1.8 million in Medicare savings during Performance Period 3 of the Centers for Medicare &amp; Medicaid Services’ Enhancing Oncology Model (EOM) through its California professional corporation, with savings equating to more than $6,400 per patient episode. This represents a significant increase from Performance Period 2, when TOI generated $1.1 million in savings, or more than $3,500 per episode.</p> <p>For the second consecutive performance period, TOI earned the maximum score on avoidable emergency department visits http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Achieves+%241.8+Million+in+Medicare+Savings+in+CMS+Enhancing+Oncology+Model+Performance+Period+3%2C+Marking+Significant+Period-Over-Period+Improvement/26303732.html Mon, 13 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Achieves+%241.8+Million+in+Medicare+Savings+in+CMS+Enhancing+Oncology+Model+Performance+Period+3%2C+Marking+Significant+Period-Over-Period+Improvement/26303732.html <p>CERRITOS, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, achieved $1.8 million in Medicare savings during Performance Period 3 of the Centers for Medicare &amp; Medicaid Services’ Enhancing Oncology Model (EOM) through its California professional corporation, with savings equating to more than $6,400 per patient episode. This represents a significant increase from Performance Period 2, when TOI generated $1.1 million in savings, or more than $3,500 per episode.</p> <p>For the second consecutive performance period, TOI earned the maximum score on avoidable emergency department visits http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Achieves+%241.8+Million+in+Medicare+Savings+in+CMS+Enhancing+Oncology+Model+Performance+Period+3%2C+Marking+Significant+Period-Over-Period+Improvement/26303732.html Mon, 13 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Achieves+%241.8+Million+in+Medicare+Savings+in+CMS+Enhancing+Oncology+Model+Performance+Period+3%2C+Marking+Significant+Period-Over-Period+Improvement/26303732.html <p>CERRITOS, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, achieved $1.8 million in Medicare savings during Performance Period 3 of the Centers for Medicare &amp; Medicaid Services’ Enhancing Oncology Model (EOM) through its California professional corporation, with savings equating to more than $6,400 per patient episode. This represents a significant increase from Performance Period 2, when TOI generated $1.1 million in savings, or more than $3,500 per episode.</p> <p>For the second consecutive performance period, TOI earned the maximum score on avoidable emergency department visits http://www.streetinsider.com/Globe+Newswire/The+Oncology+Institute+Achieves+%241.8+Million+in+Medicare+Savings+in+CMS+Enhancing+Oncology+Model+Performance+Period+3%2C+Marking+Significant+Period-Over-Period+Improvement/26303732.html Mon, 13 Apr 2026 09:00:00 -0400 O.21802973 TOI TOIIW http://www.streetinsider.com/Corporate+News/Ascertain+partners+with+Oncology+Institute+on+AI+automation+system/25606815.html <p>Ascertain, a healthcare technology company, announced a partnership with The Oncology Institute Inc. (NASDAQ: TOI) to develop automated administrative workflows for oncology practices. The collaboration focuses on Ascertain's Unified Payer Portal, an AI system designed to automate payer-related tasks before outpatient oncology visits.</p><p>The companies deployed the system in eight weeks from signed agreement to implementation. Since launching in September 2025, the automation reduced office visit authorization submission time by over 80 percent at pilot sites, according to the companies' statement.</p><p>The Oncology Institute expects the system to generate up to $2 million in operating expense savings in 2026 as it scales http://www.streetinsider.com/Corporate+News/Ascertain+partners+with+Oncology+Institute+on+AI+automation+system/25606815.html Thu, 13 Nov 2025 16:05:37 -0400 TOI TOIIW http://www.streetinsider.com/Corporate+News/Ascertain+partners+with+Oncology+Institute+on+AI+automation+system/25606815.html <p>Ascertain, a healthcare technology company, announced a partnership with The Oncology Institute Inc. (NASDAQ: TOI) to develop automated administrative workflows for oncology practices. The collaboration focuses on Ascertain's Unified Payer Portal, an AI system designed to automate payer-related tasks before outpatient oncology visits.</p><p>The companies deployed the system in eight weeks from signed agreement to implementation. Since launching in September 2025, the automation reduced office visit authorization submission time by over 80 percent at pilot sites, according to the companies' statement.</p><p>The Oncology Institute expects the system to generate up to $2 million in operating expense savings in 2026 as it scales http://www.streetinsider.com/Corporate+News/Ascertain+partners+with+Oncology+Institute+on+AI+automation+system/25606815.html Thu, 13 Nov 2025 16:05:37 -0400 TOI TOIIW http://www.streetinsider.com/Press+Releases/Ascertain+and+The+Oncology+Institute+Co-Develop+%E2%80%98Touchless%E2%80%99+AI+Automation+for+Oncology+Administration/25606708.html <p align="left">CERRITOS, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- <strong>Ascertain</strong>, a healthcare technology company pioneering agentic AI to automate administrative workflows, and <strong>The Oncology Institute, Inc. (NASDAQ: TOI)</strong>, a leading value-based oncology care provider, today announced a co-development partnership to create “near-touchless” administrative workflows that reduce manual interactions between providers and payers.</p> <p>The collaboration centers on <strong>Ascertain’s Unified Payer Portal (UPP)</strong> — an AI-powered automation module that streamlines payer-related tasks required ahead of outpatient oncology visits. The system enables near-touchless workflows by automating manual data entry, documentation submission, and payer portal navigation, significantly reducing http://www.streetinsider.com/Press+Releases/Ascertain+and+The+Oncology+Institute+Co-Develop+%E2%80%98Touchless%E2%80%99+AI+Automation+for+Oncology+Administration/25606708.html Thu, 13 Nov 2025 16:04:00 -0400 A.04232622 A.30746152 O.00173928 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/Ascertain+and+The+Oncology+Institute+Co-Develop+%E2%80%98Touchless%E2%80%99+AI+Automation+for+Oncology+Administration/25606708.html <p align="left">CERRITOS, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- <strong>Ascertain</strong>, a healthcare technology company pioneering agentic AI to automate administrative workflows, and <strong>The Oncology Institute, Inc. (NASDAQ: TOI)</strong>, a leading value-based oncology care provider, today announced a co-development partnership to create “near-touchless” administrative workflows that reduce manual interactions between providers and payers.</p> <p>The collaboration centers on <strong>Ascertain’s Unified Payer Portal (UPP)</strong> — an AI-powered automation module that streamlines payer-related tasks required ahead of outpatient oncology visits. The system enables near-touchless workflows by automating manual data entry, documentation submission, and payer portal navigation, significantly reducing http://www.streetinsider.com/Press+Releases/Ascertain+and+The+Oncology+Institute+Co-Develop+%E2%80%98Touchless%E2%80%99+AI+Automation+for+Oncology+Administration/25606708.html Thu, 13 Nov 2025 16:04:00 -0400 A.04232622 A.30746152 O.00173928 O.21802973 TOI TOIIW http://www.streetinsider.com/Press+Releases/Ascertain+and+The+Oncology+Institute+Co-Develop+%E2%80%98Touchless%E2%80%99+AI+Automation+for+Oncology+Administration/25606708.html <p align="left">CERRITOS, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- <strong>Ascertain</strong>, a healthcare technology company pioneering agentic AI to automate administrative workflows, and <strong>The Oncology Institute, Inc. (NASDAQ: TOI)</strong>, a leading value-based oncology care provider, today announced a co-development partnership to create “near-touchless” administrative workflows that reduce manual interactions between providers and payers.</p> <p>The collaboration centers on <strong>Ascertain’s Unified Payer Portal (UPP)</strong> — an AI-powered automation module that streamlines payer-related tasks required ahead of outpatient oncology visits. The system enables near-touchless workflows by automating manual data entry, documentation submission, and payer portal navigation, significantly reducing http://www.streetinsider.com/Press+Releases/Ascertain+and+The+Oncology+Institute+Co-Develop+%E2%80%98Touchless%E2%80%99+AI+Automation+for+Oncology+Administration/25606708.html Thu, 13 Nov 2025 16:04:00 -0400 A.04232622 A.30746152 O.00173928 O.21802973 TOI TOIIW